World self-medication industry
The world federation promoting better health through responsible self-medication
NGO in official relations with the World Health Organization

The switch of Zocor

On May 12, the UK’s Medicines and Healthcare products Regulatory Agency approved the prescription to nonprescription switch of Zocor (simvastatin), 10 mg, to reduce the risk of a first major coronary event in people who are likely to be at moderate risk of coronary heart disease. Zocor will be the first statin to be sold without a prescription in the world. It will be available from behind the pharmacist’s counter. The agency emphasized that the case was made convincingly that the balance of potential health benefits and any possible risks is overwhelmingly positive. WSMI member association in the UK PAGB  applauded the move, pointing out that it takes self-care to a new level, focusing on preventing a serious illness, not just treating self-limiting conditions.

Array ( [0] => stdClass Object ( [term_id] => 1 [name] => News [slug] => news [term_group] => 0 [term_taxonomy_id] => 1 [taxonomy] => category [description] => WSMI News [parent] => 0 [count] => 156 [object_id] => 1856 [filter] => raw [cat_ID] => 1 [category_count] => 156 [category_description] => WSMI News [cat_name] => News [category_nicename] => news [category_parent] => 0 ) )
Brian McNamara New Chair of WSMI

The Board of Directors of WSMI has elected Mr

read more

UK Study shows a disconnect between how people view self-care and how they act

The “Self Care Nation Report”, commissioned by

read more

Global Study: Men’s Health Perceptions from around the Globe

The results of the survey show that 87 % of men

read more